I fearlessly predict it will say nothing of note.
Occasionally they drop in a few "where did that come from" nuggets, like FXTAS. About which we could also say "where did that go?"
I don't recall ever seeing a really new piece of information in the annual report, and let's face it that's not their purpose. The most useful thing may be that we might see how the company is framing things at the moment.
I would like to see concrete information about the bread and butter critical path stuff (manufacturing, toxicology) but we'll just have to see. Given the usual discussions-are-confidential stuff, I don't see how we can expect to get any information about how deals might be progressing. If they did suddenly drop news of a deal it would be coincidence not design.
- Forums
- ASX - By Stock
- NEU
- Annual report
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.40%
!
$17.09
Annual report, page-2
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
